CDNA has resolved corporate instability and insurance issues, showing potential for sustainable growth with innovative transplant testing services like AlloSure, AlloMap, and HeartCare. CDNA's ...
This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American In a unanimous decision last month, the ...
I reiterate a “Buy” rating for Advanced Micro Devices with a fair value of $205 per share, driven by strong R&D and growth prospects. AMD's upcoming Instinct MI325X and future MI350 and MI400 series, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback